Skip to content

Clinical trials

Withdrawn Lymphoma, T-Cell, Peripheral trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Status: Withdrawn Country / region: United States Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20141
20151
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Conjupro Biotherapeutics, Inc.1
Eisai Inc.1
Fred Hutchinson Cancer Center1
Rhizen Pharmaceuticals SA1
University of Medicine and Dentistry of New Jersey1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral5
Burkitt Lymphoma2
Hodgkin Disease2
Immunoblastic Lymphadenopathy2
Intraocular Lymphoma2
Leukemia, Hairy Cell2
Leukemia, Large Granular Lymphocytic2
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Extranodal NK-T-Cell2

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.